NOVARTIS PHARMA GMBH
Patent Owner
Stats
- 8 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- May 28, 2013 most recent publication
Details
- 8 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 166 Total Citation Count
- Sep 04, 2001 Earliest Filing
- 10 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8450272 Combinations of somatostatin-analogs with different selectivity for human somatostatin receptor subtypesFeb 07, 07May 28, 13[A61K, A61P, C07K]
8343984 Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamideJul 18, 06Jan 01, 13[A61K, A01N, C07D]
8163904 Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-BenzamideJul 18, 06Apr 24, 12[A61K, C07D, A61P]
8105587 Methods of treating arthritis using IL-1β binding moleculesOct 24, 06Jan 31, 12[A61K, C12P, C07K]
7713976 [(1H-indol-5-yl)-heteroaryloxy]-1-aza-bicylco[3.3.1]nonanes as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenerative disordersDec 14, 06May 11, 10[A61K, C07D]
7713977 (1-aza-bicyclo[3.3.1]non-4-yl)-[5-(1H-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disordersDec 14, 06May 11, 10[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
8012477 Methods of treating multiple myeloma using IL-17 binding moleculesExpiredJan 30, 07Sep 06, 11[A61K]
2009/0197,902 Use of Pyrimidine Compounds in the Preparation of ParasiticidesAbandonedFeb 27, 09Aug 06, 09[A01P, A01N]
2009/0136,965 Use of antibody-ligand binding to characterise diseasesAbandonedMay 08, 06May 28, 09[G01N]
2008/0139,551 TUMOR NECROSIS FACTOR ALPHA INHIBITORS AND THEIR USE IN THE TREATMENT OF HUMAN DISEASESAbandonedAug 21, 07Jun 12, 08[A61K, A61P]
6740672 Use of 5HT3-receptor antagonists for the treatment of chronic fatigue syndromeExpiredSep 04, 01May 25, 04[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.